JMT106 Injection in the Treatment of Advanced Solid Tumors

NCT07275073 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Lung Squamous Cell Carcinoma
Hepatocellular Carcinoma

Interventions

DRUG: JMT106 Injection

Sponsor

Shanghai JMT-Bio Inc.